235 related articles for article (PubMed ID: 20930463)
1. Accurate detection of drug-induced delayed ventricular repolarization with a suitable correction formula in Langendorff guinea pig heart.
Tabo M; Komatsu R; Isobe T; Honda M; Yamada Y; Kimura K
J Toxicol Sci; 2010 Oct; 35(5):687-98. PubMed ID: 20930463
[TBL] [Abstract][Full Text] [Related]
2. Monophasic action potential in anaesthetized guinea pigs as a biomarker for prediction of liability for drug-induced delayed ventricular repolarization.
Tabo M; Kimura K; Ito S
J Pharmacol Toxicol Methods; 2007; 55(3):254-61. PubMed ID: 17229580
[TBL] [Abstract][Full Text] [Related]
3. Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
Sakaguchi Y; Takahara A; Nakamura Y; Akie Y; Sugiyama A
Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):43-8. PubMed ID: 18699795
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs.
Kågström J; Sjögren EL; Ericson AC
J Pharmacol Toxicol Methods; 2007; 56(2):186-93. PubMed ID: 17582787
[TBL] [Abstract][Full Text] [Related]
5. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.
Takahara A; Sugiyama A; Hashimoto K
Br J Pharmacol; 2005 Oct; 146(4):561-7. PubMed ID: 16056235
[TBL] [Abstract][Full Text] [Related]
6. New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts.
Kui P; Orosz S; Takács H; Sarusi A; Csík N; Rárosi F; Csekő C; Varró A; Papp JG; Forster T; Farkas AS; Farkas A
J Pharmacol Toxicol Methods; 2016; 80():26-34. PubMed ID: 27063345
[TBL] [Abstract][Full Text] [Related]
7. Isolated perfused and paced guinea pig heart to test for drug-induced changes of the QT interval.
Cheng HC; Incardona J; McCullough B
J Pharmacol Toxicol Methods; 2006; 54(3):278-87. PubMed ID: 16507347
[TBL] [Abstract][Full Text] [Related]
8. Comparison of four rate-correction algorithms for the ventricular repolarization period in assessing net effects of IKr blockers in dogs.
Takahara A; Sugiyama A; Satoh Y; Hashimoto K
J Pharmacol Sci; 2006 Dec; 102(4):396-404. PubMed ID: 17130672
[TBL] [Abstract][Full Text] [Related]
9. QT-RR relationships and suitable QT correction formulas for halothane-anesthetized dogs.
Tabo M; Nakamura M; Kimura K; Ito S
J Toxicol Sci; 2006 Oct; 31(4):381-90. PubMed ID: 17077591
[TBL] [Abstract][Full Text] [Related]
10. In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity.
De Clerck F; Van de Water A; D'Aubioul J; Lu HR; van Rossem K; Hermans A; Van Ammel K
Fundam Clin Pharmacol; 2002 Apr; 16(2):125-40. PubMed ID: 12031065
[TBL] [Abstract][Full Text] [Related]
11. Preclinical QT safety assessment: cross-species comparisons and human translation from an industry consortium.
Holzgrefe H; Ferber G; Champeroux P; Gill M; Honda M; Greiter-Wilke A; Baird T; Meyer O; Saulnier M
J Pharmacol Toxicol Methods; 2014; 69(1):61-101. PubMed ID: 23689033
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and electrophysiological effects of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin in a halothane-anesthetized canine model.
Kimura K; Tabo M; Mizoguchi K; Kato A; Suzuki M; Itoh Z; Omura S; Takanashi H
J Toxicol Sci; 2007 Aug; 32(3):231-9. PubMed ID: 17785940
[TBL] [Abstract][Full Text] [Related]
13. Validation of a guinea pig Langendorff heart model for assessing potential cardiovascular liability of drug candidates.
Guo L; Dong Z; Guthrie H
J Pharmacol Toxicol Methods; 2009; 60(2):130-51. PubMed ID: 19616638
[TBL] [Abstract][Full Text] [Related]
14. Drugs and ventricular repolarization in a general population: the Rotterdam Study.
Niemeijer MN; van den Berg ME; Franco OH; Hofman A; Kors JA; Stricker BH; Eijgelsheim M; Rijnbeek PR
Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1036-41. PubMed ID: 26248883
[TBL] [Abstract][Full Text] [Related]
15. Rate-corrected QT interval: techniques and limitations.
Funck-Brentano C; Jaillon P
Am J Cardiol; 1993 Aug; 72(6):17B-22B. PubMed ID: 8256750
[TBL] [Abstract][Full Text] [Related]
16. Correction of QT values to allow for increases in heart rate in conscious Beagle dogs in toxicology assessment.
Tattersall ML; Dymond M; Hammond T; Valentin JP
J Pharmacol Toxicol Methods; 2006; 53(1):11-9. PubMed ID: 15886026
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent effects on cisapride-induced QTc prolongation in the isolated guinea pig heart.
Mittelstadt SW; Adams NA; Spruell RD
J Pharmacol Toxicol Methods; 2006; 54(2):159-63. PubMed ID: 16624595
[TBL] [Abstract][Full Text] [Related]
18. QT and RR intervals in conscious and anesthetized guinea pigs with highly varying RR intervals and given QTc-lengthening test articles.
Hamlin RL; Kijtawornrat A; Keene BW; Hamlin DM
Toxicol Sci; 2003 Dec; 76(2):437-42. PubMed ID: 14600288
[TBL] [Abstract][Full Text] [Related]
19. The best QT correction formula in a non-hospitalized population: the Fasa PERSIAN cohort study.
Yazdanpanah MH; Naghizadeh MM; Sayyadipoor S; Farjam M
BMC Cardiovasc Disord; 2022 Feb; 22(1):52. PubMed ID: 35172723
[TBL] [Abstract][Full Text] [Related]
20. Problems of heart rate correction in assessment of drug-induced QT interval prolongation.
Malik M
J Cardiovasc Electrophysiol; 2001 Apr; 12(4):411-20. PubMed ID: 11332559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
